Alaska Air Group (ALK) ended the recent trading session at $40.74, demonstrating a -3.09% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of ...

Alaska Air stock (NYSE: ALK) is up nearly 20% in this month after the company raised its Q4 outlook. Alaska now expects its Q4 earnings to be in the range of $0.40 and $0.50 per share, versus its ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Alaska Air (NYSE: ALK) has experienced a challenging year, with its price declining by 15% and notably lagging behind both the S&P 500’s 15% increase and its competitors. This downturn can be ...

Ensacove is approved for ALK-positive NSCLC patients who haven't received prior ALK-inhibitors, offering a new first-line treatment option. The eXALT3 trial showed Ensacove significantly improved ...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) to launch its adrenaline autoinjector (AAI), Jext®, in China via a partnership with leading supplier of adrenaline, Grandpharma. Jext® is expected to be the ...